Literature DB >> 10755341

Treatment of impending and actual pathological femoral fractures with the long Gamma nail in The Netherlands.

R van Doorn1, J W Stapert.   

Abstract

OBJECTIVE: To compare the results of stabilising impending and actual pathological femoral fractures using the long Gamma nail with the published results of other methods.
DESIGN: Retrospective study.
SETTING: 20 hospitals throughout The Netherlands. PATIENTS: 101 patients with metastases in 110 femurs, which were stabilised with a long Gamma nail. MAIN OUTCOME MEASURES: Functional results and complications.
RESULTS: Minimum follow-up was 1.5 years or until death, Mean survival was 12 months (range 0-82). 14 patients died in hospital; 5 had technical complications and fat embolism was suspected in 3 patients. 92% of the patients became mobile and pain was absent or acceptable in 93%.
CONCLUSION: The use of the long Gamma nail produces better functional results, fewer technical complications, and an incidence of general complications no different from those reported for other methods.

Entities:  

Mesh:

Year:  2000        PMID: 10755341     DOI: 10.1080/110241500750009366

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  15 in total

1.  Subtrochanteric metastatic lesions treated with the long gamma nail.

Authors:  S R Samsani; V Panikkar; D Georgiannos; D Calthorpe
Journal:  Int Orthop       Date:  2003-06-11       Impact factor: 3.075

2.  Mechanical failure of the long gamma nail in two proximal femur fractures.

Authors:  Soheil Najibi; Lemos Mark; David Fehnel
Journal:  Iowa Orthop J       Date:  2010

3.  What Factors Are Associated With Implant Breakage and Revision After Intramedullary Nailing for Femoral Metastases?

Authors:  Julie J Willeumier; Mustafa Kaynak; Peer van der Zwaal; Sven A G Meylaerts; Nina M C Mathijssen; Paul C Jutte; Panagiotis Tsagozis; Rikard Wedin; Michiel A J van de Sande; Marta Fiocco; P D Sander Dijkstra
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

4.  Surgery for pathological proximal femoral fractures, excluding femoral head and neck fractures: resection vs. stabilisation.

Authors:  Max Zacherl; Gerald Gruber; Mathias Glehr; Petra Ofner-Kopeinig; Roman Radl; Manfred Greitbauer; Vilmos Vecsei; Reinhard Windhager
Journal:  Int Orthop       Date:  2010-12-01       Impact factor: 3.075

Review 5.  Fatigue failure of the cephalomedullary nail: revision options, outcomes and review of the literature.

Authors:  Adam Tucker; Michael Warnock; Sinead McDonald; Laurence Cusick; Andrew P Foster
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-10-17

6.  Endoprostheses last longer than intramedullary devices in proximal femur metastases.

Authors:  Norah Harvey; Elke R Ahlmann; Daniel C Allison; Lingjun Wang; Lawrence R Menendez
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

7.  C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.

Authors:  Costantino Errani; Monica Cosentino; Giovanni Ciani; Lorenzo Ferra; Patricio A Alfaro; Barbara Bordini; Davide M Donati
Journal:  Int Orthop       Date:  2021-01-04       Impact factor: 3.075

8.  Simultaneous nailing of skeletal metastases: is the mortality really that high?

Authors:  Bryan Moon; Patrick Lin; Robert Satcher; Valerae Lewis
Journal:  Clin Orthop Relat Res       Date:  2011-02-17       Impact factor: 4.176

Review 9.  Treatment for long bone metastases based on a systematic literature review.

Authors:  Costantino Errani; Andreas F Mavrogenis; Luca Cevolani; Silvia Spinelli; Andrea Piccioli; Giulio Maccauro; Nicola Baldini; Davide Donati
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-09-20

10.  Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome.

Authors:  Bill Ristevski; Richard J Jenkinson; David J G Stephen; Joel Finkelstein; Emil H Schemitsch; Michael D McKee; Hans J Kreder
Journal:  Can J Surg       Date:  2009-08       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.